Squarepoint’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Squarepoint’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50,349	Closed	-$157K	–	4359
2023 Q2	$157K	Buy	+50,349	New	+$150K	﹤0.01%	3282
2022 Q1	–	Sell	-30,880	Closed	-$142K	–	3693
2021 Q4	$142K	Buy	+30,880	New	+$102K	﹤0.01%	2832
2021 Q1	–	Sell	-12,428	Closed	-$127K	–	3739
2020 Q4	$127K	Buy	+12,428	New	+$136K	﹤0.01%	2667
2020 Q2	–	Sell	-12,670	Closed	-$120K	–	2583
2020 Q1	$120K	Buy	+12,670	New	+$163K	﹤0.01%	1604

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Squarepoint's GRTX Position: Q3 2023 in Review

Squarepoint sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2023, closing a stake of 50,349 shares — an estimated $157K sold.

Squarepoint first reported a position in GRTX in Q1 2020 and held it in 4 quarters. The position peaked at $157K in Q2 2023. 38 funds tracked by Wall St. Rank hold GRTX as of Q3 2023.

Squarepoint reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Squarepoint sold 50,349 Galera Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $157K.
Squarepoint first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
Squarepoint's Galera Therapeutics, Inc. Common Stock position peaked at $157K in Q2 2023.
38 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.